Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers

Authors

• Eric J. Duncavage, Washington University School of Medicine in St. Louis
• Molly C. Schroeder, Washington University School of Medicine in St. Louis
• Michele O'Laughlin, Washington University School of Medicine in St. Louis
• Roxanne Wilson, Washington University School of Medicine in St. Louis
• Sandra MacMillan, Washington University School of Medicine in St. Louis
• Andrew Bohannon, Washington University School of Medicine in St. Louis
• Scott Kruchowski, Washington University School of Medicine in St. Louis
• John Garza, Washington University School of Medicine in St. Louis
• Feiyu Du, Washington University School of Medicine in St. Louis
• Andrew E.O. Hughes, Washington University School of Medicine in St. Louis
• Josh Robinson, Washington University School of Medicine in St. Louis
• Emma Hughes, Washington University School of Medicine in St. Louis
• Sharon E. Heath, Washington University School of Medicine in St. Louis
• Jack D. Baty, Washington University School of Medicine in St. Louis
• Julie Neidich, Washington University School of Medicine in St. Louis
• Matthew J. Christopher, Washington University School of Medicine in St. Louis
• Meagan A. Jacoby, Washington University School of Medicine in St. Louis
• Geoffrey L. Uy, Washington University School of Medicine in St. Louis
• Robert S. Fulton, Washington University School of Medicine in St. Louis
• Christopher A. Miller, Washington University School of Medicine in St. Louis
• Jacqueline E. Payton, Washington University School of Medicine in St. Louis
• Daniel C. Link, Washington University School of Medicine in St. Louis
• Matthew J. Walter, Washington University School of Medicine in St. Louis
• Peter Westervelt, Washington University School of Medicine in St. Louis
• John F. DiPersio, Washington University School of Medicine in St. Louis
• Timothy J. Ley, Washington University School of Medicine in St. Louis
• David H. Spencer, Washington University School of Medicine in St. Louis

Journal

New England Journal of Medicine

Publication Date

2021

Volume

384

Issue

10

First Page

924

Last Page

935

Document Type

Open Access Publication

DOI

10.1056/NEJMoa2024534

Rights and Permissions

Duncavage EJ, Schroeder MC, O'Laughlin M, Wilson R, MacMillan S, Bohannon A, Kruchowski S, Garza J, Du F, Hughes AEO, Robinson J, Hughes E, Heath SE, Baty JD, Neidich J, Christopher MJ, Jacoby MA, Uy GL, Fulton RS, Miller CA, Payton JE, Link DC, Walter MJ, Westervelt P, DiPersio JF, Ley TJ, Spencer DH. Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers. N Engl J Med. 2021 Mar 11;384(10):924-935. doi: 10.1056/NEJMoa2024534 Copyright © 2021 Massachusetts Medical Society. All rights reserved.

Recommended Citation

Duncavage, Eric J.; Schroeder, Molly C.; O'Laughlin, Michele; Wilson, Roxanne; MacMillan, Sandra; Bohannon, Andrew; Kruchowski, Scott; Garza, John; Du, Feiyu; Hughes, Andrew E.O.; Robinson, Josh; Hughes, Emma; Heath, Sharon E.; Baty, Jack D.; Neidich, Julie; Christopher, Matthew J.; Jacoby, Meagan A.; Uy, Geoffrey L.; Fulton, Robert S.; Miller, Christopher A.; Payton, Jacqueline E.; Link, Daniel C.; Walter, Matthew J.; Westervelt, Peter; DiPersio, John F.; Ley, Timothy J.; and Spencer, David H., "Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers." New England Journal of Medicine. 384, 10. 924 - 935. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10796